[1]
“Consensus molecular subtypes (CMS) in metastatic colorectal cancer- personalized decision medicine”, Radiol Oncol, vol. 54, no. 3, pp. 272–277, Sep. 2020, Accessed: Sep. 22, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/3427